InO - A Retrospective Study of UK Patients With Leukaemia
NCT04456959
·
clinicaltrials.gov ↗
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Interventions
DRUG:
Inotuzumab Ozogamicin
Sponsor
Pfizer